Healthcare -
Biotechnology - NASDAQ - US
$ 3.91
-1.01 %
$ 42.2 M
Market Cap
-2.2
P/E
LTRN - TOTAL EQUITY
Total Equity LTRN - Lantern Pharma Inc.
40.9 M
LAST VALUE
-24.40%
2 YEAR CAGR
189.89%
5 YEAR CAGR
0.00%
10 YEAR CAGR